Clayton, S.A.; Mizener, A.D.; Whetsell, M.A.; Rentz, L.E.; Meadows, E.M.; Geldenhuys, W.J.; Pistilli, E.E.
Preclinical Multi-Omic Assessment of Pioglitazone in Skeletal Muscles of Mice Implanted with Human HER2/neu Overexpressing Breast Cancer Xenografts. Cancers 2024, 16, 3640.
https://doi.org/10.3390/cancers16213640
AMA Style
Clayton SA, Mizener AD, Whetsell MA, Rentz LE, Meadows EM, Geldenhuys WJ, Pistilli EE.
Preclinical Multi-Omic Assessment of Pioglitazone in Skeletal Muscles of Mice Implanted with Human HER2/neu Overexpressing Breast Cancer Xenografts. Cancers. 2024; 16(21):3640.
https://doi.org/10.3390/cancers16213640
Chicago/Turabian Style
Clayton, Stuart A., Alan D. Mizener, Marcella A. Whetsell, Lauren E. Rentz, Ethan M. Meadows, Werner J. Geldenhuys, and Emidio E. Pistilli.
2024. "Preclinical Multi-Omic Assessment of Pioglitazone in Skeletal Muscles of Mice Implanted with Human HER2/neu Overexpressing Breast Cancer Xenografts" Cancers 16, no. 21: 3640.
https://doi.org/10.3390/cancers16213640
APA Style
Clayton, S. A., Mizener, A. D., Whetsell, M. A., Rentz, L. E., Meadows, E. M., Geldenhuys, W. J., & Pistilli, E. E.
(2024). Preclinical Multi-Omic Assessment of Pioglitazone in Skeletal Muscles of Mice Implanted with Human HER2/neu Overexpressing Breast Cancer Xenografts. Cancers, 16(21), 3640.
https://doi.org/10.3390/cancers16213640
